On Friday, Senseonics Holdings (NYSE: SENS) surged in value, ending the day up over 40%.
Due to this dramatic price action, many investors have been trying to find out how to buy Senseonics stock. Handily, we can help explain why this has happened and what you can do to get involved.
This article lists the best places to buy Senseonics shares and explains what they have to offer. In addition, we provide a SENS price prediction to give you an indication of what to expect.
Where to buy Senseonics stock online
If you are looking to invest in Senseonics, your best option is a reliable stockbroker. These are comprehensive platforms that enable you to control a diverse investment portfolio including stocks, commodities, forex and cryptocurrencies.
Furthermore, the two platforms below have extremely low fees, meaning you can keep more of your profits:
CedarFX is an eco-conscious broker offering 0% commission trading on 170+ assets, including Forex, Cryptocurrency Pairs, Stocks, Indices and Commodities. With up to 1:500 leverage, no-fee transactions and low spreads, traders can make the most of their funds. CedarFX also offers an Eco Account option to support tree planting and sustainability projects.
Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.
What is Senseonics?
SENS is a medical technology company, and its primary area of focus is glucose monitoring products. It was originally known as ASN Technologies and was incorporated in Nevada back in 2014.
Using its continuous glucose monitoring (CGM) systems, called Eversense and Eversense XL, the company aims to aid disease management for many of the hundreds of millions of diabetes sufferers internationally.
Current CGM systems can only measure glucose levels accurately for six to fourteen days, while Eversense can do the same job for up to 90 days in regular form, and 180 days in its XL iteration.
Why is SENS stock rising in value?
Thanks to strong results following the company’s 2-year PROMISE trial, which tested the 180-day efficacy of Eversense when compared to conventional glucose monitoring systems. This is an essential precondition for FDA and EU EMA approval, and it now appears there are few hurdles left before commercialisation of the product.
Should I buy SENS stock today?
If you believe in the company’s credentials and the prospects for long term value creation, and you have conducted the necessary due diligence, SENS shares are worth a look.
SENS price prediction
The consensus amongst most analysts for a 12-month price prediction is a high of $4, though it is worth noting that this is a marathon, not a sprint, and things won’t always be straightforward.
Senseonics is a long-term investment proposition and should be approached as such, though catalyst moments may create value in the short term.
2021 could be the year that diabetes experiences another blow, and it could be a profitable one too.